Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence

Summary

The objective of this study is to demonstrate that a larger proportion of vigabatrin-treated subjects than placebo-treated subjects will be methamphetamine-free in the last 2 weeks of the study's Treatment Phase (Weeks 11 and 12).

Timeline

Start

2008-07

Primary completion

2009-06

Completion

2009-11

Drugs

Indications